Products

Products

Cat Bite Rabies Vaccine With Complete Vaccination Schedule

A complete vaccination process is an important part of rabies prevention after cat-related injuries. AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. provides Cat Bite Rabies Vaccine With Complete Vaccination Schedule as a professional rabies vaccine solution for medical institutions and healthcare partners requiring standardized post-exposure protection procedures. As an experienced rabies vaccine supplier, AIM Honor focuses on Vero cell vaccine technology, production quality, and stable supply capability.

After a cat bite or scratch, vaccination alone is not the only important step. A complete rabies prevention procedure includes immediate wound treatment, exposure evaluation, vaccine administration according to schedule, and completion of all required doses. Proper management helps support the development of protective antibodies after possible exposure.

AIM Honor provides conventional Vero cell rabies vaccine and new generation serum-free Vero cell rabies vaccine options. These products are developed to meet professional medical application needs and support standardized rabies prevention programs.

Cat Bite Rabies Vaccine With Complete Vaccination Schedule

Complete Vaccination Process

The vaccination schedule after cat-related exposure should follow professional medical evaluation and recommended procedures. Completing the full vaccination course is important because interrupted vaccination may affect the establishment of effective immune protection.

Post Exposure Steps

A standardized response process usually includes the following important stages:

1. Immediate wound treatment: Clean the wound with soap water or clean water for more than 15 minutes, then disinfect according to professional recommendations.

2. Exposure assessment: Healthcare professionals evaluate the injury type, wound condition, and animal information to determine the appropriate prevention approach.

3. Vaccination initiation: Start vaccination according to medical recommendations after exposure evaluation.

4. Schedule completion: Complete all required vaccine doses according to the recommended timetable to support immune response development.

Vaccination Timeline

Cat bite exposure requires attention to vaccination timing. According to the provided product information, the commonly used intramuscular vaccination schedule for Category II and Category III exposure includes five doses on days 0, 3, 7, 14, and 28.

Vaccination Time Procedure Purpose
Day 0 First vaccination dose Begin immune response activation after exposure
Day 3 Second vaccination dose Continue immune system stimulation
Day 7 Third vaccination dose Support antibody development process
Day 14 Fourth vaccination dose Strengthen immune protection response
Day 28 Fifth vaccination dose Complete the standard vaccination course

Why Schedule Completion Matters

Rabies vaccination requires a complete course because the immune system needs appropriate stimulation over time. Following the recommended schedule helps healthcare providers manage post-exposure prevention more effectively.

1. Consistent immune stimulation: Multiple doses support continuous immune response development.

2. Better vaccination management: A clear timetable helps patients and healthcare providers track vaccination progress.

3. Standardized prevention: Completing the recommended course supports professional rabies prevention procedures.

Exposure Management

Cat-related injuries can happen in different situations, including household pet accidents, stray cat encounters, and animal-related work environments. Proper exposure management helps reduce risks and supports timely medical intervention.

Different Exposure Situations

1. Pet cat bites: Even domestic cats may require professional assessment when bites break the skin or when vaccination status is uncertain.

2. Stray cat injuries: Stray or unknown-status cats require special attention because the animal health condition may not be confirmed.

3. Multiple exposure environments: Animal handlers and veterinary professionals may require awareness of rabies prevention procedures due to frequent animal contact.

Vaccine Technology

A complete vaccination schedule requires reliable vaccine products supported by professional manufacturing technology. AIM Honor develops rabies vaccine solutions based on Vero cell culture technology, providing conventional and serum-free options for different healthcare requirements.

Vero Cell Production Platform

Vero cell culture technology is an important production platform used in biological product manufacturing. AIM Honor applies this technology to rabies vaccine development and production, focusing on product consistency, safety management, and immune response performance.

According to the provided product information, the conventional rabies vaccine uses the indigenous aG strain, while the serum-free Vero cell rabies vaccine uses the PV-2061 strain. Both solutions are designed to support professional rabies prevention after possible exposure.

Immune Response Characteristics

The effectiveness of a vaccination program depends on both product quality and completion of the recommended vaccination procedure. AIM Honor’s vaccine products are developed with high immunogenicity characteristics to support antibody production after vaccination.

According to the provided product data, the seroconversion rate reaches 100% at 14 days after vaccination, and the neutralizing antibody level exceeds the WHO protective threshold of 0.5IU/ml.

1. Immune activation: Vaccination stimulates the immune system to recognize rabies virus components and develop protective antibodies.

2. Protection development: Completing the vaccination schedule supports the formation of effective immune protection.

3. Professional guidance: Healthcare professionals evaluate exposure conditions and provide appropriate vaccination recommendations.

Technical Parameters

For hospitals, CDC organizations, distributors, and healthcare partners, understanding product specifications is important when selecting a rabies vaccine supplier. The following information is based on the product materials provided by AIM Honor.

Parameter Conventional Vero Cell Rabies Vaccine Serum-Free Vero Cell Rabies Vaccine
Vaccine Type Inactivated rabies vaccine Inactivated rabies vaccine
Production Method Vero cell culture technology Serum-free Vero cell culture technology
Virus Strain Indigenous aG strain PV-2061 strain
Application Purpose Post-exposure rabies prevention Post-exposure rabies prevention with serum-free process
Seroconversion Rate 100% at 14 days after vaccination according to provided information 100% at 14 days after vaccination according to provided information
Antibody Level Exceeds WHO protective threshold of 0.5IU/ml Exceeds WHO protective threshold of 0.5IU/ml
Special Feature No preservatives added Serum-free production process throughout manufacturing

Quality Assurance

AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. focuses on pharmaceutical quality management throughout research, production, and supply. The company provides professional rabies prevention solutions based on standardized manufacturing processes and technical experience.

Manufacturing Control

Reliable vaccine production requires strict management of raw materials, production procedures, and quality evaluation. AIM Honor follows professional pharmaceutical manufacturing practices to support product reliability.

1. Process management: Standardized production procedures are applied throughout vaccine manufacturing.

2. Quality evaluation: Products undergo quality assessment before supply according to pharmaceutical requirements.

3. Continuous improvement: AIM Honor continues to optimize technology and manufacturing capability to support healthcare needs.

Product Qualification

According to the provided company information, the conventional rabies vaccine has obtained National Drug Approval Number S20073014 and maintained a 100% batch release qualification rate for 17 years.

The serum-free Vero cell rabies vaccine has completed Phase III clinical trials, and the marketing authorization application has been accepted by the Center for Drug Evaluation (CDE). The production process complies with WHO Specifications for the Use of Biological Products Raw Materials.

Procurement Value

For professional buyers, vaccine procurement involves more than product selection. Stable supply capability, technical support, and manufacturing experience are also important factors when choosing a long-term partner.

AIM Honor provides cooperation support for customers requiring Cat Bite Rabies Vaccine With Complete Vaccination Schedule, helping healthcare organizations establish reliable rabies prevention solutions.

1. Stable supply experience: AIM Honor products have been supplied for a long time to more than 2000 CDC institutions and medical institutions across China.

2. Product selection flexibility: Customers can select conventional Vero cell rabies vaccine or serum-free Vero cell rabies vaccine according to application requirements.

3. Professional cooperation: AIM Honor provides product communication and cooperation support for healthcare partners and distributors.

AIM Honor Advantage

AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. focuses on biological pharmaceutical development and vaccine manufacturing. With professional experience in rabies vaccine production, the company provides reliable solutions for healthcare institutions, distributors, and professional partners.

For organizations searching for Cat Bite Rabies Vaccine With Complete Vaccination Schedule, AIM Honor combines vaccine technology, manufacturing capability, and supply experience to support different rabies prevention programs.

Company Capability

AIM Honor continues to improve vaccine production technology and quality management systems. The company provides both conventional Vero cell rabies vaccine and new generation serum-free Vero cell rabies vaccine solutions to meet different market requirements.

According to the provided company information, AIM Honor vaccine products have been supplied for a long time to more than 2000 CDC institutions and medical institutions across China, demonstrating practical experience in vaccine application and supply management.

Global Cooperation Support

AIM Honor supports cooperation with international customers by providing professional product information and communication services. The company works with healthcare-related organizations to contribute to global rabies prevention and control.

1. Distributor cooperation: Support professional partners requiring stable rabies vaccine products and cooperation solutions.

2. Medical institution support: Provide product information for hospitals, clinics, and healthcare organizations.

3. Long-term partnership: Focus on building reliable cooperation through professional service and stable supply capability.

Frequently Asked Questions

Q: Why is completing the rabies vaccination schedule important after a cat bite?

A: Completing the vaccination schedule helps support continuous immune response development after possible rabies exposure. The recommended vaccination procedure allows the immune system to receive appropriate stimulation over time and helps healthcare professionals manage post-exposure prevention more effectively.

Q: What is the usual vaccination schedule after a cat bite?

A: According to the provided product information, the commonly used intramuscular vaccination schedule for Category II and Category III exposure includes doses on days 0, 3, 7, 14, and 28. The final vaccination plan should be determined by healthcare professionals according to individual exposure conditions.

Q: Should I clean the wound before receiving rabies vaccination?

A: Yes. Immediate wound cleaning is an important part of rabies prevention after cat-related injuries. The wound should be washed with soap water or clean water for more than 15 minutes and disinfected according to professional recommendations before receiving medical evaluation.

Q: Does AIM Honor provide rabies vaccine products based on Vero cell technology?

A: Yes. AIM Honor provides Vero cell rabies vaccine solutions, including conventional Vero cell rabies vaccine and serum-free Vero cell rabies vaccine. These products are developed for professional rabies prevention applications.

Q: What are the differences between conventional and serum-free rabies vaccines?

A: The conventional vaccine uses the indigenous aG strain and the serum-free vaccine uses the PV-2061 strain. The serum-free product adopts a serum-free culture process throughout manufacturing, while both products focus on supporting effective rabies prevention.

Q: Who can purchase AIM Honor rabies vaccine products?

A: AIM Honor products are suitable for professional buyers including medical institutions, CDC organizations, distributors, and healthcare-related partners requiring reliable rabies prevention solutions.

Conclusion

A complete rabies prevention process requires timely wound management, professional exposure evaluation, and following the recommended vaccination procedure. AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. provides professional vaccine solutions supported by Vero cell technology, standardized manufacturing, and long-term supply experience.

For healthcare organizations and professional buyers looking for Cat Bite Rabies Vaccine With Complete Vaccination Schedule, AIM Honor offers reliable products and cooperation support. Through continuous improvement in vaccine technology and quality management, the company contributes to stronger rabies prevention systems worldwide.

Hot Products

  • Adult Meningitis Vaccine

    Adult Meningitis Vaccine

    AIM Persistence Biopharmaceutical Co., Ltd. is a professional vaccine manufacturer. We offer the Adult Meningitis Vaccine, a quadrivalent meningococcal polysaccharide vaccine, which is a crucial measure to help adults stay safe from the threat of meningitis. Our product is highly safe, has a long shelf life, and provides reliable immune protection.
  • Children Hepatitis A Vaccine

    Children Hepatitis A Vaccine

    Looking for a reliable manufacturer and supplier of Children Hepatitis A Vaccine? Consider AIM Action Biopharmaceutical Co., Ltd. We have our own R&D and manufacturing facilities. This vaccine is designed for the delicate constitution and rapidly developing immune system of children, providing a 0.5ml child-specific dose (containing 320 EU of Hepatitis A virus), striking a balance between safety and effective response.
  • Vaccines for Hajj

    Vaccines for Hajj

    AIM Persistence Biopharmaceutical Co., Ltd. is a meningitis vaccine supplier from China. We provide vaccines for Hajj, offering high safety, long shelf life, and not just monovalent or bivalent meningococcal vaccines, but quadrivalent meningococcal vaccines, providing comprehensive coverage and all-around protection.
  • Anti-Hepatitis A Virus Vaccine

    Anti-Hepatitis A Virus Vaccine

    AIM Action Biopharmaceutical Co., Ltd. is a professional vaccine manufacturer. Our Anti-Hepatitis A Virus Vaccine is a preventive biological product prepared using modern biotechnology, strictly adhering to national pharmaceutical manufacturing quality management standards. It effectively stimulates the body to produce high-titer protective antibodies, thereby establishing an immune barrier against the hepatitis A virus.
  • Hyposensitivity Rabies Vaccine

    Hyposensitivity Rabies Vaccine

    AIM Honor is a reliable manufacturer of hyposensitivity rabies vaccines, based in China with comprehensive R&D and production capabilities. Our serum-free Vero cell rabies vaccine, a typical low-allergen vaccine, avoids sensitization risks from the source through a completely serum-free culture process. We strictly control the amount of excipients to improve purity, and clinical trials have shown an allergic reaction rate of less than 0.5%, while achieving a 100% antibody seroconversion rate.
  • Intramuscular Rabies Vaccine

    Intramuscular Rabies Vaccine

    AIM Honor, a reliable manufacturer of rabies vaccines, offers both conventional and serum-free versions, both of which are Intramuscular Rabies Vaccines. The conventional version boasts a mature manufacturing process and a 100% batch release qualification rate over 17 years, while the serum-free version is an innovative formulation adapted to diverse scenarios. Both offer highly effective immunity.

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies.Privacy Policy
RejectAccept